Showing results (191-200 of 313) with videos related to

Sort By:
Pageof 32
Diabetes|December 20, 2013
Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individualsGiuseppe Daniele, Roy Eldor, Aurora Merovci, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 15, 2002
Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjectsThongchai Pratipanawatr, Wilailak Pratipanawatr, Clifford Rosen, et al.
BMC Endocrine Disorders|August 24, 2019
Glycated hemoglobin versus oral glucose tolerance test in the identification of subjects with prediabetes in Qatari populationSaadallah Iskandar, Ayman Migahid, Dalia Kamal, et al.
Diabetes Care|July 8, 2025
Changes in β-Cell Function and Insulin Sensitivity During Treatment With Dapagliflozin Alone or in Combination With Exenatide in Type 2 DiabetesCurtis Triplitt, Eugenio Cersosimo, Mariam Alatrach, et al.
American Journal of Physiology. Endocrinology and Metabolism|August 27, 2010
NF-κB activity in muscle from obese and type 2 diabetic subjects under basal and exercise-stimulated conditionsPuntip Tantiwong, Karthigayan Shanmugasundaram, Adriana Monroy, et al.
The Journal of Clinical Endocrinology and Metabolism|May 13, 2022
Effects of Sustained Hyperglycemia on Skeletal Muscle Lipids in Healthy SubjectsChristopher E Shannon, Aurora Merovci, Marcel Fourcaudot, et al.
Human Brain Mapping|May 8, 2019
A neural signature of metabolic syndromeEithan Kotkowski, Larry R Price, Crystal Franklin, et al.
The Journal of Biological Chemistry|December 16, 2004
Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscleDawn K Richardson, Sangeeta Kashyap, Mandeep Bajaj, et al.
Diabetes Care|March 1, 2023
Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM PatientsSiham Abdelgani, Ahmed Khattab, John Adams, et al.
The Journal of Clinical Endocrinology and Metabolism|July 22, 2023
Emergence of a New Glucoregulatory Mechanism for Glycemic Control With Dapagliflozin/Exenatide Therapy in Type 2 DiabetesEugenio Cersosimo, Mariam Alatrach, Carolina Solis-Herrera, et al.
Pageof 32